Drugs
Friday, 15 Nov 2019

Former Deputy Head of China's Drug Regulator Sentenced to 16 Years in Prison

Publisher: The Insight Partners

Wu Zhen, a former deputy head of China’s food and drug regulator, was sentenced to 16 years in prison by a Chinese court, state television reported on Friday.

Wu is one of the senior officials from the regulator who has been under investigation after a safety scandal at vaccine maker Changsheng Biotechnology Co Ltd.

The company was accused last year of falsifying data for a rabies vaccine and manufacturing an ineffective vaccine for babies, sparking widespread consumer anger.

Read here

Related Industry Updates

Sickle Cell Disease Treatment Market is expected to reach US$ 4,691.87 million by 2030
Nov 07, 2023

Luye Pharma Submits New Drug Application in the U.S. for Its Antidepressant Drug LY03005
Dec 27, 2019

What Is Human Serum Albumin and How It Drives Modern Medicine
Feb 25, 2026

FDA Approves Harmony Biosciences' Sleep Disorder Drug
Sep 04, 2019

See how South Africa Anti-Infective Market is Changes during 2019-2027 with an increase in Revenue of $2572.5Mn| Sanofi, Abbott, Pfizer
Oct 27, 2020

GeneQuantum Healthcare (GQ) receives IND clearance by the US FDA for ADC drug
Jun 11, 2020

The ITC Complaint Against Estar Medical in the U.S. Is Withdrawn by Regenlab
Mar 05, 2020

Follow us on

Related News

Medical / Feb 05, 2024

Monoclonal Antibody Therapeutics (mABs) Market is expected to reach US$ 542.80 billion by 2030

Medical / Oct 11, 2023

Vitamin K2 Market is expected to reach US$ 11,60,779.02 Thousands by 2030

Medical / May 06, 2021

Synthetic Menthol Market Overview | COVID-19 Pandemic Impact, Competitive Landscape, Size, Value Demand, Regional Analysis and Forecast to 2027

Medical / Oct 23, 2023

India Lymphedema Treatment Market is expected to reach US$ 1,511.06 million by 2030